Dejan Antonic Email & Phone Number

Serbia

Belgrade, Serbia

Belgrade, Serbia

June 2014 – September 2018: General Manager PharmaSwiss Serbia & Montenegro80 mill. USD annual turnover. 300 employees. 7 direct report. Goals and achievements: 2nd position at the pharmaceutical market by the market share (2014-2018).Team effectiveness improvement by recruiting, selecting, orienting, training, coaching, counseling, and disciplining managers; communicating values, strategies, and objectives; monitoring, and appraising job results; developing incentives… Show more June 2014 – September 2018: General Manager PharmaSwiss Serbia & Montenegro80 mill. USD annual turnover. 300 employees. 7 direct report. Goals and achievements: 2nd position at the pharmaceutical market by the market share (2014-2018).Team effectiveness improvement by recruiting, selecting, orienting, training, coaching, counseling, and disciplining managers; communicating values, strategies, and objectives; monitoring, and appraising job results; developing incentives. Having Management of key external stakeholders. Development of strategic plan. Leading plan and budgeting process. Resources allocation.Marketing, compliance, field force, commercial, procurement, production, quality and technical services coordination. Building company image by collaborating with customers, government, community organizations and employees. Enforcement of ethical business practices.Business development activities to bring new products to the market and ensure further business growth in line with the company strategic goals. 15% of organic growth in the first year.Keeps OPEX and EBITA under strict control. Partnership management of all multinational partners. Show less

Prague, The Capital, Czech Republic

Act as one of the central coordination points for interaction between Valeant and external partners (BMS, Ipsen, Astellas, Norgine, Recordati, Temmler, Novintethical, Eisai, Gentium, Helsinn) and implementation of broad marketing initiatives for partner's portfolios. Collect, review and refine the regular marketing reports from 15 markets and act as an interface for consolidated reporting to the partners. Driving / Coordinating performance of the key partner products. Development of… Show more Act as one of the central coordination points for interaction between Valeant and external partners (BMS, Ipsen, Astellas, Norgine, Recordati, Temmler, Novintethical, Eisai, Gentium, Helsinn) and implementation of broad marketing initiatives for partner's portfolios. Collect, review and refine the regular marketing reports from 15 markets and act as an interface for consolidated reporting to the partners. Driving / Coordinating performance of the key partner products. Development of positioning, branding elements, key messages platform and marketing / tactical strategy guidelines for Valeant generic or in-licensed products. Identification of organizational competency needs in marketing and implementation of development programs to meet those needs. Leading and coordinating Valeant EMEA aesthetic dermatology portfolio (Sculptra, Obagi Medical, Fraxel, Liposonix, Vaser, Thermage) launch activities and marketing support in over 30 countries across the region. Product trainings planing and organisation. Certified regional trainer for Obagi Medical cosmetics. Member of Valeant EMEA Business Development team with a responsibility for providing strategic perspective of portfolio development. Show less

Prague, The Capital, Czech Republic

Act as one of the central coordination points for interaction between Valeant and external partners (BMS, Ipsen, Astellas, Ferring, Norgine, Recordati, Temmler, Novintethical, Eisai, Gentium, Helsinn) and implementation of broad marketing initiatives for partner's portfolios. Collect, review and refine the regular marketing reports from 15 markets and act as an interface for consolidated reporting to the partners. Driving / Coordinating performance of the key partner products. Development of… Show more Act as one of the central coordination points for interaction between Valeant and external partners (BMS, Ipsen, Astellas, Ferring, Norgine, Recordati, Temmler, Novintethical, Eisai, Gentium, Helsinn) and implementation of broad marketing initiatives for partner's portfolios. Collect, review and refine the regular marketing reports from 15 markets and act as an interface for consolidated reporting to the partners. Driving / Coordinating performance of the key partner products. Development of positioning, branding elements, key messages platform and marketing / tactical strategy guidelines for Valeant generic or in-licensed products. Identification of organizational competency needs in marketing and implementation of development programs to meet those needs. Member of Valeant Business Development team with a responsibility for providing strategic perspective of portfolio development. Show less

Act as one of the central coordination points for interaction between PharmaSwiss and external partners (BMS, Ipsen, Astellas, Ferring...) for implementation of broad marketing initiatives for partner portfolios. Collect, review, refine with the markets, the regular marketing reports and act as an interface for consolidated reporting to the partners. Driving/Coordinating performance on the key partner products. Developing and coordinating implementation of PharmaSwiss own (generic or licencing)… Show more Act as one of the central coordination points for interaction between PharmaSwiss and external partners (BMS, Ipsen, Astellas, Ferring...) for implementation of broad marketing initiatives for partner portfolios. Collect, review, refine with the markets, the regular marketing reports and act as an interface for consolidated reporting to the partners. Driving/Coordinating performance on the key partner products. Developing and coordinating implementation of PharmaSwiss own (generic or licencing) products positioning elements and branding strategies, key messages platforms, specific marketing tactics and strategies guidelines ready for each specific market adaptation. Following the local implementation and execution of all centrally developed marketing tools. Leading the activities of few Brand Teams for PharmaSwiss own Brands. Support the local markets in customizing the brand strategies to their specific needs, managing the brand budgets, sales projections and products sales forecasting. Implementing the marketing / commercial strategies, monitoring the results against plans and budgets. Specific products P&L follow up. Supporting local marketing teams in local KOLs development and management. Organising central marketing and medical events to support local activities for specific generic products. Creating / organising / implementing new product training programs for local teams. Identification of organizational competency needs in Marketing and implementation of development programs to meet those needs. Responsible for coordination of core products activities and marketing plans implementation in 18 countries (CEE + Greece and Israel). Main fields of expertise: cardiovascular as the field with the most activities and focuse for almost 10 years of experience covering the full range of CV products; rheumatology, neuroscience, immunosuppressant, non steroid anti-inflammatory drugs, pain killers, specific OTC products and food supplements. Show less

Leading marketing operation of pharmaceutical portfolio. Responsible for conducting of Standard Operating Procedures (SOP). Business development - cardiovascular, nephrology, diabetes and immunosuppressant area. Developing and implementing marketing plans and specific project programs. Product positioning and pricing strategies, sales forecasting. Market research and market analysis activities. Product launches plan preparation, implementation and follow up.

Heading up main Business Units for Macedonia and Kosovo, build organisation, HR, finance and business development. Responsible for sales and marketing of ethical and OTC products for the territories of Macedonia & Kosovo. Oversee 2 third parties.

Responsible for sales and marketing of cardiovascular and immunosuppressant portfolio. Launch of first new generation immunosuppressive product after 10 years of cyclosporine monopoly at the market. Driving Key Accounts, OLs and decision makers in Serbia & Montenegro. Achieved fast growth of 50%+, with turnover of 1 million Euro in the first year.

Belgrade, Serbia

Cardiovascular and metabolic portfolio (Dilatrend, Xenical, Recormon team). Product champion in 2000. Roche Award for Excellence in 2001. Line person responsible for organisation of events (round tables, symposia, congresses participation, workshops).

Master, Medical Faculty

Licentiate Degree, Aesthetician/Esthetician And Skin Care Specialist